IIFL View
Go
  • NTPC

    NTPC Ltd is likely to see revenue CAGR of 9.7%, over FY18-20E, aided by a (1) total capacity addition (standalone basis) of ~5GW over FY19-20E, and (2) falling under recoveries. This revenue growth to lead to PAT CAGR of 10.7% over FY18-20E with an EBITDA m...

    Buy Reco. Price: 148.00

  • CESC

    CESC is likely to see revenue CAGR of 6.1% over FY18-20E aided by PPA opportunities for power generation business. As on 30 October, the company has demerged the Retail (Spencers) and CESC Ventures businesses. We expect PAT CAGR of 18% over FY18-20...

    Buy Reco. Price: 688.20

  • GE Power

    We expect GE Power to report revenue CAGR of 8% over FY18-20E, aided by (1) growth in order book prompted by increasing capex on emission control equipment by thermal plants, and (2) improved execution of existing orders. EBITDA margins are likely to expand...

    Buy Reco. Price: 810.00

  • Idea Cellular

    Vodafone Idea is facing intense competition; hence we expect revenue CAGR of 20.3% over FY18-20E leading to an EBITDA margin of 21.1% in FY20E. Revenue growth would be supported by a significant growth in data revenues over FY18-20E. EBITDA margin is ex...

    Reduce Reco. Price: 37.30

  • Indian Energy Ex

    Indian Energy Exchange Ltd (IEX) is a power exchange that is likely to benefit from (1) expected addition of 100GW of  renewable energy capacity by 2022, and (2) growing participation of power discoms on power exchanges. We expect IEX’s trading v...

    Buy Reco. Price: 164.00

  • Hind.Zinc

    Hindustan Zinc Ltd (HZL) is likely to see a revenue CAGR of 9.4% over FY18-20E, aided by (a) ramp up of production volumes, and (b) firm pricing supported by deficits in zinc and lead inventory levels globally. We expect EBITDA margin expansion of ~131bps o...

    Accumulate Reco. Price: 278.00

  • Biocon

    Biocon’s early entry in the biosimilars business is a long term positive for the company. Biocon-Mylan has recently received an approval for Trastuzumab and Pegfilgrastim in US and we expect approval to 2-3 more biosimilars in 2019/2020 across US and ...

    Buy Reco. Price: 610.00

  • Tata Chemicals

    The global market for soda ash is expected to stabilize leading to firmness in soda ash realizations with full absorption of additional capacities in Turkey. TCL’s international business is likely to recover during H2FY19 with full utilization level i...

    Buy Reco. Price: 705.00

  • Bajaj Finserv

    AUM of Bajaj Finance, the lending vertical of Bajaj Finserv is expected to grow at CAGR of ~30% over FY18-20E, aided by ~60% CAGR in lifestyle finance and ~45% CAGR in personal-loan-cross-sell segments. Sharp traction across most segments and favourable bor...

    Buy Reco. Price: 6,088.00

  • Coromandel Inter

    Coromandel International (CIL) is looking for strategic tie-ups to provide assurance and sustain its supply of raw materials. Phosphoric acid, a key raw material in fertilizer, is likely to see enhanced domestic production. This will be supported by commenc...

    Buy Reco. Price: 442.00